Lineage Cell Therapeutics
LCTX
#7625
Rank
ยฃ0.28 B
Marketcap
ยฃ1.24
Share price
-2.92%
Change (1 day)
202.23%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -ยฃ15.53 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ10.81 Million. In 2024 the company made an earning of -ยฃ16.04 Million, an increase over its 2023 earnings that were of -ยฃ18.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ15.53 Million-3.24%
2024 -ยฃ16.04 Million-13.16%
2023 -ยฃ18.48 Million9.83%
2022 -ยฃ16.82 Million-54.24%
2021 -ยฃ36.76 Million86.07%
2020 -ยฃ19.76 Million-31.97%
2019 -ยฃ29.04 Million-5.42%
2018 -ยฃ30.7 Million1.1%
2017 -ยฃ30.37 Million-31.06%
2016 -ยฃ44.04 Million-10.38%
2015 -ยฃ49.15 Million29.69%
2014 -ยฃ37.9 Million31.68%
2013 -ยฃ28.78 Million
2011 -ยฃ13.97 Million89.78%
2010 -ยฃ7.36 Million206.06%
2009 -ยฃ2.41 Million-0.58%
2008 -ยฃ2.42 Million164.89%
2007 -ยฃ0.92 Million-30.22%
2006 -ยฃ1.31 Million
2002 -ยฃ1.52 Million-41.04%
2001 -ยฃ2.58 Million-32.04%
2000 -ยฃ3.8 Million-11.85%
1999 -ยฃ4.31 Million
1997 -ยฃ2.77 Million12.12%
1996 -ยฃ2.47 Million106.25%
1995 -ยฃ1.2 Million-11.11%
1994 -ยฃ1.35 Million50%
1993 -ยฃ0.9 Million20%
1992 -ยฃ0.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA